Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
Shelley N FacenteEduard GrebeKatie BurkMeghan D MorrisEdward L MurphyAli MirzazadehAaron A SmithMelissa A SanchezJennifer L EvansAmy NishimuraHenry F Raymondnull nullPublished in: PloS one (2018)
We estimated approximately 7,400 (51%) more HCV seropositive cases than are included in San Francisco's HCV surveillance case registry. Our estimate provides a useful baseline against which the impact of End Hep C SF can be measured.